TITLE

Hematologic Effects of Linezolid versus Vancomycin

AUTHOR(S)
Young, Lowell S.
PUB. DATE
April 2004
SOURCE
Clinical Infectious Diseases;4/15/2004, Vol. 38 Issue 8, p1065
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
When linezolid was first approved for use in the United States in the spring of 2000, it was the first oral and parenteral antimicrobial agent to receive indications for the treatment of both infection with vancomycin-resistant enterococci and infection with methicillin-resistant Staphylococcus aureus. Among clinicians, there were concerns about this compound from the time it became available regarding its bacteriostatic nature, early reports of the development of resistance, its high acquisition costs, and its hematologic toxicity-principally thrombocytopenia.
ACCESSION #
13015083

 

Related Articles

  • Vancomycin-Resistant Staphylococcus aureus in the Clinic: Not Quite Armageddon. Bush, Karen // Clinical Infectious Diseases;4/15/2004, Vol. 38 Issue 8, p1056 

    In 1992, reported that they could transfer the vancomycin-resistant genes vanA, vanH, vanX, and vanY from vancomycin-resistant enterococci to a strain of Staphylococcus aureus both in vitro and on the skin of an obese mouse. However, after waiting 10 years, some clinicians concluded that this...

  • Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region. Yuen, K. Y.; Cheng, Vincent C. C.; Chan, Jasper F. W.; Tai, Josepha W. M.; Ho, Y. Y.; Li, Iris W. S.; To, Kelvin K. W.; Ho, P. L. // Emerging Health Threats;2009, Vol. 2, p1 

    Vancomycin-resistant enterococci (VRE) have emerged in many parts of the world but have only been reported sporadically in Hong Kong. We report an outbreak of vancomycin-resistant Enterococcus faecium (VREfm) in a neurosurgical unit at a tertiary teaching hospital between 3 March and 3 April...

  • Surveillance of Vancomycin-resistant Enterococci colonization with GeneXpert vanA/vanB test and culture method. Altun, Hatice Uludağ; Hatipoğlu, Çiğdem Ataman; Bulut, Cemal; Yağcı, Server; Ertem, Günay Tuncer; Kınıklı, Sami; Demiröz, Ali Pekcan // Journal of Microbiology & Infectious Diseases;Sep2014, Vol. 4 Issue 3, p97 

    Objectives: Early detection of vancomycin resistant enterococci (VRE) colonization in hospitalized patients plays an important role in controlling enterococcal infections. For this purpose, the detection of VRE from rectal swab specimens can be performed with various methods. Methods: In this...

  • LINEZOLID VANCOMYCIN RESISTANT ENTEROCOCCUS ISOLATED FROM CLINICAL SAMPLES IN TEHRAN HOSPITALS. Yasliani, S.; Mohabati Mobarez, A.; Doust, R. Hosseini; Satari, M.; Teymornejad, O. // Indian Journal of Medical Sciences;Jul2009, Vol. 63 Issue 7, p297 

    BACKGROUND: Vancomycin-resistant enterococci pose an emerging health risk. The limitation in therapeutic options has resulted in the development of new drugs such as quinupristin/ dalfopristin and linezolid. AIM, SETTING AND DESIGN: This study investigated the species prevalence and...

  • Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium. Ntokou, Eleni; Stathopoulos, Constantinos; Kristo, Ioulia; Dimitroulia, Evangelia; Labrou, Maria; Vasdeki, Afroditi; Makris, Demosthenes; Zakynthinos, Epameinondas; Tsakris, Athanassios; Pournaras, Spyros // Journal of Antimicrobial Chemotherapy (JAC);Aug2012, Vol. 67 Issue 8, p1819 

    Objectives Outbreaks caused by linezolid-resistant (LR) enterococci remain rare. We report the epidemiological and molecular characteristics of the multiclonal dissemination of LR enterococci in the intensive care unit (ICU) of a Greek hospital. Methods All LR enterococcal isolates recovered...

  • Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis. Lee, J.-H.; Yoon, J.-H.; Kim, B. H.; Chung, G. E.; Myung, S. J.; Kim, W.; Kim, Y. J.; Kim, E.-C.; Lee, H.-S. // European Journal of Clinical Microbiology & Infectious Diseases;Jan2009, Vol. 28 Issue 1, p21 

    Clinicians sometimes experience treatment failure in the initial empirical antibiotics treatment using cephalosporins in cirrhotic patients with spontaneous bacterial peritonitis (SBP). Enterococcus, which is intrinsically resistant to cephalosporins, may be one of the causes of treatment...

  • Vancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment. Zirakzadeh, Ali; Patel, Robin // Mayo Clinic Proceedings;Apr2006, Vol. 81 Issue 4, p529 

    Vancomycin-resistant enterococci (VRE) are becoming a major concern in medical practice. Their increased prevalence and their ability to transfer vancomycin resistance to other bacteria (including methicillin-resistant Staphylococcus aureus) have made them a subject of close scrutiny and intense...

  • First Antibiotic in New Class of Drugs Fights Resistant Infections.  // FDA Consumer;Jul/Aug2000, Vol. 34 Issue 4, p4 

    Reports that the first in a class of antibacterial drugs to treat serious infections resistant to other antibiotics has been approved by the United States Food and Drug Administration (FDA). Qualities of Zyvox, or linezolid; Incidence of vancomycin-resistant Enterococcus faecium (VREF);...

  • Vancomycin Revisited. Cook, Francis V.; Farrar Jr., W. Edmund // Annals of Internal Medicine;Jun78, Vol. 88 Issue 6, p813 

    Discusses the resurgence of the use of vancomycin which was virtually discarded after development of antistaphylococcal penicillins. Advantages over other antimicrobial agents; Way to minimize problems caused by vancomycin; Analysis of the pharmacokinetics of vancomycin; Therapy complication...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics